Status:
COMPLETED
Co-infection Management in COVID-19 Critically Ill
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborating Sponsors:
BioMérieux
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
International guidelines suggest the administration of empirical broad-spectrum antibiotics for suspected bacterial co-infection in COVID-19 critically ill. However, data on associated respiratory inf...
Detailed Description
At the end of April 2020, the World Health Organisation reported that nearly three million people worldwide were infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of whom ...
Eligibility Criteria
Inclusion
- Adult patients remaining at the intensive care (SIM, SIT) of the CUSL with a confirmed COVID-19 infection
Exclusion
- Patients from whom no respiratory sample can be obtained or
- Patients benefitting from palliative care or
- Insufficient volume of the respiratory sample after routine testing to perform the FA-PNEU test.
Key Trial Info
Start Date :
March 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 24 2020
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04382092
Start Date
March 23 2020
End Date
April 24 2020
Last Update
May 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint-Luc
Brussels, Belgium, 1200